BEAM is trading 4.1% down today at $34.09 after a strong multi-day rally, as a broader risk-off tone hits technology and growth names.
- The move aligns with a wider market downturn, with major indices including the S&P 500 and Nasdaq trading sharply lower.
- No fresh company-specific news has emerged for Beam Therapeutics, suggesting the pullback is driven by sector-wide profit-taking rather than a fundamental reset.